(Q73327826)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622679%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

0 references

title

The incidence of cancer associated with the treatment of rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622679%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622679%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

P Beauparlant

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622679%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

B Haraoui

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622679%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622679%20AND%20SRC:MED&resulttype=core&format=json

Seminars in Arthritis and Rheumatism

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622679%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622679%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

148-158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622679%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622679%20AND%20SRC:MED&resulttype=core&format=json

Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Epidemiology and estimated population burden of selected autoimmune diseases in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Length of life and cause of death in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

The association of immune disease and malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Mortality among arthritics

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Death Rate and Causes of Death in Patients with Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Increased mortality in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Cause of death in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

The mortality of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Rheumatoid arthritis and lymphatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Incidence of Cancer Among Patients With Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Rheumatoid arthritis and cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Cancer morbidity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Cancer and rheumatoid arthritis: epidemiologic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Occurrence of malignant neoplasms in the Rochester, Minnesota, rheumatoid arthritis cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

The risk of cancer in rheumatoid patients in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Rheumatoid arthritis and the risk of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Record linkage to conduct an epidemiologic study on the association of rheumatoid arthritis and lymphoma in the Province of Saskatchewan, Canada.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

The incidence of malignant disease in patients receiving cytotoxic therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Risk of cancer in renal-transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Aggressive squamous cell carcinomas developing in patients receiving long-term azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Association between azathioprine therapy and lymphoma in rheumatoid disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Side-effects of azathioprine treatment in rheumatoid arthritis: analysis of 10 years of experience

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Carcinoma of the Urinary Bladder after Treatment with Cyclophosphamide for Non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Leukemia after therapy with alkylating agents for childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Bladder Complications in Patients Receiving Cyclophosphamide for Systemic Lupus Erythematosus or Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Bladder malignancy in a patient receiving low dose cyclophosphamide for treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Malignancy following treatment of rheumatoid arthritis with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Lymphoma developing in a patient with rheumatoid arthritis taking methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Study of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Methotrexate-associated lymphoma in patients with rheumatoid arthritis: report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Reversible cutaneous lymphoma occurring during methotrexate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Epstein-Barr virus clonality in lymphomas occurring in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Low-dose methotrexate treatment of rheumatoid arthritis; long-term observation of efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

The use of cyclosporin A microemulsion in rheumatoid arthritis: conclusions of an international review

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Cancer in rheumatoid arthritis: a prospective long-term study of mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Cancer morbidity in rheumatoid arthritis patients treated with Proresid or parenteral gold

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Increased Risk of Lymphoma in Sicca Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Non-Hodgkin's lymphoma in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Different defects of T cell regulation of Epstein-Barr virus-induced B cell activation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Comparison of blood and synovial fluid lymphocyte subsets in rheumatoid arthritis and osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Frequency of malignant neoplasms in 248 long-term methotrexate-treated psoriatics. A preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Methotrexate used for psoriasis and the risk of noncutaneous or cutaneous malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

Ten year mortality and causes of death in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980026-2

7 January 2021

10.1016/S0049-0172(99)80026-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622679%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference